Solvay Pharmaceuticals, Inc. Chooses Quad-Core Intel Xeon Processors to Virtualize Its Data Center
Continuous new product development is a hallmark of the pharmaceutical industry, and Solvay Pharmaceuticals, Inc. (Solvay) depends on its IT infrastructure to support a growing research and development program. One of the Solvay IT team's most challenging tasks is rapidly deploying the latest applications to keep up with that growth. The Solvay IT team decided to address these challenges by virtualizing and consolidating its data center servers. IT team members tested several servers and were impressed with the HP ProLiant DL380, a two-processor platform based on the Quad-Core Intel Xeon processor 5300 series.